About 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol
2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol (PubChem CID 171779145) has the molecular formula C28H25ClF6N4O2
and a molecular weight of 598.98 g/mol. Its IUPAC name is 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol.
Molecular Properties
| Compound Name | 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol |
| PubChem CID | 171779145 |
| Molecular Formula | C28H25ClF6N4O2 |
| Molecular Weight | 598.98 g/mol |
| Exact Mass | 598.16 |
| IUPAC Name | 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol |
| SMILES | Oc1c(-c2cc(C(F)(F)F)[nH]n2)ccc(C#CCCN2CCN(C3COC3)CC2)c1-c1ccc(Cl)c(C(F)(F)F)c1 |
| InChI | InChI=1S/C28H25ClF6N4O2/c29-22-7-5-18(13-21(22)27(30,31)32)25-17(3-1-2-8-38-9-11-39(12-10-38)19-15-41-16-19)4-6-20(26(25)40)23-14-24(37-36-23)28(33,34)35/h4-7,13-14,19,40H,2,8-12,15-16H2,(H,36,37) |
| InChIKey | TVTKJVYYPAAPSV-UHFFFAOYSA-N |
| XLogP | 5.90 |
| TPSA | 64.62 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 598.98 |
| LogP ≤ 5 | 5.90 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Analyze 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol?
The IUPAC name of 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol (CID 171779145) is 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol.
What is the SMILES notation for 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol?
The canonical SMILES for 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol is Oc1c(-c2cc(C(F)(F)F)[nH]n2)ccc(C#CCCN2CCN(C3COC3)CC2)c1-c1ccc(Cl)c(C(F)(F)F)c1.
What is the InChIKey of 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol?
The InChIKey is TVTKJVYYPAAPSV-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H25ClF6N4O2/c29-22-7-5-18(13-21(22)27(30,31)32)25-17(3-1-2-8-38-9-11-39(12-10-38)19-15-41-16-19)4-6-20(26(25)40)23-14-24(37-36-23)28(33,34)35/h4-7,13-14,19,40H,2,8-12,15-16H2,(H,36,37).
What are the key properties of 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol?
2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol has a molecular weight of 598.98 g/mol, XLogP of 5.90, 5 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(oxetan-3-yl)piperazin-1-yl]but-1-ynyl]-6-[5-(trifluoromethyl)-1H-pyrazol-3-yl]phenol is sourced from PubChem (CID 171779145), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).